Johnson & Johnson (JNJ)

Check out top investors' recommendation for JNJ
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
138.33
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
67%/33%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and women’s health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON’S, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDÔME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Sector:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Vamil Divan Credit Suisse Buy   Jun 12, '18     151.00  Jun 12, '19  N/A 
Dane Leone Macquarie Research Equities Sell   May 21, '18     110.00  May 21, '19  N/A 
Vamil Divan Credit Suisse Buy   Apr 12, '18     154.00  Apr 12, '19  N/A 
Jeffrey Holford Jefferies & Co. Buy   Jan 16, '18     170.00  Jan 16, '19  N/A 
Larry Biegelsen Wells Fargo Securities, Llc Buy   Jan 12, '18     160.00  Jan 12, '19  N/A 
Joanne Wuensch BMO Capital Markets Buy   Dec 12, '17     161.00  Dec 12, '18  N/A 
Amit Hazan Suntrust Robinson Humphrey Buy   Oct 23, '17     149.00  Oct 23, '18  N/A 
Vamil Divan Credit Suisse Buy   Oct 19, '17     154.00  Oct 19, '18  N/A 
Danielle Antalffy Leerink Swann Llc Buy   Oct 18, '17     165.00  Oct 18, '18  N/A 
David Toung Argus Research Company Buy   Oct 18, '17     165.00  Oct 18, '18  N/A 
Joanne Wuensch BMO Capital Markets Buy   Oct 17, '17     152.00  Oct 17, '18  N/A 
Jeffrey Holford Jefferies & Co. Buy   Oct 11, '17       Oct 11, '18  N/A 
Larry Biegelsen Wells Fargo Securities, Llc Buy   Oct 09, '17       Oct 09, '18  N/A 
Glenn Novarro RBC Capital Markets Buy   Oct 09, '17       Oct 09, '18  N/A 
Josh Jennings Cowen And Company Buy   Oct 06, '17     147.00  Oct 06, '18  N/A 
Charles Graham Unaffiliated Sell   Sep 28, '17     1.00  Sep 28, '18  N/A 
Jami Rubin Goldman Sachs Sell   Sep 20, '17     130.00  Sep 20, '18  N/A 
Joanne Wuensch BMO Capital Markets Buy   Aug 31, '17     145.00  Aug 31, '18  N/A 
Matt Miksic Piper Jaffray Buy   Aug 31, '17     148.00  Aug 31, '18  N/A 
Glenn Novarro RBC Capital Markets Buy   Aug 27, '17     138.00  Aug 27, '18  N/A 
< previous123